Baseline pain characteristics predict pain reduction after physical therapy in women with chronic pelvic pain. Secondary analysis of data from a randomized controlled trial.


Journal

Scandinavian journal of pain
ISSN: 1877-8879
Titre abrégé: Scand J Pain
Pays: Germany
ID NLM: 101520867

Informations de publication

Date de publication:
25 10 2020
Historique:
received: 20 02 2020
accepted: 11 05 2020
pubmed: 2 7 2020
medline: 15 9 2021
entrez: 2 7 2020
Statut: ppublish

Résumé

Background and aims Women with chronic pelvic pain represent a heterogeneous group, and it is suggested that the existence of sub-groups can explain varying results and inconclusiveness in clinical trials. Some predictors of treatment outcome are suggested, but the evidence is limited. The primary aim of this study was to explore if selected pre-treatment characteristics of the participants in a recently conducted randomized controlled trial were associated with treatment outcome. Methods In this study secondary analysis of data collected in a randomized trial were conducted. The participants were women with chronic pelvic pain randomized to two different physical therapy treatments. Analyses in this study were performed for the whole group as a cohort. The primary outcome measure was change in pain intensity from baseline to 12 months, measured with the numeric rating scale (0-10). The women were asked to rate their mean pelvic pain intensity during the last 7 days. Based on previous research and on available variables from the randomized controlled trial four potential predictive factors were derived from the baseline data and assessed one by one in a linear regression model, adjusted for age and treatment group. The variables with strongest association (p < 0.10) with the primary outcome were further included in a multivariable linear regression model with backward selection, adjusted for age and treatment group. Results Fifty women (mean age 38.1, SD = 12.2) were included in the analysis. For these women the mean change in pain intensity was -1.2 points (95% CI -1.8 to -0.7) from baseline to 12 months. The multivariable regression model showed that pelvic pain duration of 6 years or more was associated with less decrease in pain intensity with a regression coefficient of 1.3 (95% CI 0.3-2.4). Baseline pain intensity was associated with higher pain reduction after PT treatment with a regression coefficient per SD increase in baseline pain of -0.6 (95% CI -1.1 to -0.1). None of the women with main pain site other places than in the pelvis reported any pain reduction after physical therapy treatment, but due to the small numbers the predictor was not included in the regression analysis. Conclusions We identified that pelvic pain duration of 6 years or more was associated with less pain reduction, and that higher baseline pain intensity was associated with higher pain reduction after physical therapy treatment in this sample of women with chronic pelvic pain. For the variable main pain site other places than the pelvis the results are unsure due to small numbers. Implications Based on our finding of long pain duration as a negative predictor for pain reduction, we emphasize that early intervention is important. Many of the participants in our RCT reported pelvic surgeries or other treatments prior to referral for PT, and we suggest that referral to a non-invasive intervention such as PT should be considered at an earlier stage. In order to tailor interventions to the individual women's needs, thorough baseline assessments, preferably in a multidisciplinary setting, should be performed.

Identifiants

pubmed: 32609653
doi: 10.1515/sjpain-2020-0026
pii: sjpain-2020-0026
doi:

Types de publication

Journal Article Randomized Controlled Trial Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

793-800

Références

EAU Guidelines. Edn. presented at the EAU Annual Congress Barcelona 2019. Arnhem, The Netherlands: EAU Guidelines Office; 2019.
Ayorinde AA, Macfarlane GJ, Saraswat L, Bhattacharya S. Chronic pelvic pain in women: an epidemiological perspective. Womens Health (Lond) 2015;11:851–64.
Cheong YC, Smotra G, Williams AC. Non-surgical interventions for the management of chronic pelvic pain (Review). Cochrane Database Syst Rev 2014;3:CD008797.
Klotz SGR, Schön M, Ketels G, Löwe B, Brünahl CA. Physiotherapy management of patients with chronic pelvic pain (CPP): a systematic review. Physiother Theory Pract 2018;28:1–17.
Allaire C, Williams C, Bodmer-Roy S, Zhu S, Arion K, Ambacher K, Wu J, Yosef A, Wong F, Noga H, Britnell S, Yager H, Bedaiwy MA, Albert AY, Lisonkova S, Yong PJ. Chronic pelvic pain in an interdisciplinary setting: 1-year prospective cohort. Am J Obstet Gynecol 2018;218:e1–12.
Dybowski C, Löwe B, Brünahl CA. Predictors of pain, urinary symptoms and quality of life in patients with chronic pelvic pain syndrome (CPPS): a prospective 12-month follow-up study. J Psychosom Res 2018;112:99–106.
Naliboff BD, Stephens AJ, Lai HH, Griffith JW, Clemens JQ, Lutgendorf S, Rodriguez LV, Newcomb C, Sutcliffe S, Guo W, Kusek JW, Landis JR, MAPP Research Network. Clinical and psychosocial predictors of urologic chronic pelvic pain symptom change over one year: a prospective study from the MAPP Research Network. J Urol 2017;198:848–57.
Rooij AD, Van Der Leeden M, Roorda LD, Steultjens MP, Dekker J. Predictors of outcome of multidisciplinary treatment in chronic widespread pain: an observational study. BMC Musculoskelet Disord 2013;14:133.
Nordstoga AL, Nilsen TIL, Vasseljen O, Unsgaard-Tøndel M, Mork PJ. The influence of multisite pain and psychological comorbidity on prognosis of chronic low back pain: longitudinal data from the Norwegian HUNT Study. BMJ Open 2017;7:e015312.
Landmark T, Dale O, Romundstad P, Woodhouse A, Kaasa S, Borchgrevink P. Development and course of chronic pain over 4 years in the general population: the HUNT pain study. Eur J Pain 2018;22:1606–16.
Schulz KF, Altman DG, Moher D, Group C. CONSORT 2010 statement: updated guidelines for reporting parallel group randomised trials. BMJ 2010;340:c332.
Mehling WE, Gopisetty V, Daubenmier J, Price CJ, Hecht FM, Stewart A. Body awareness: construct and self-report measures. PLoS One 2009;4:e5614.
Louw A, Zimney K, Puentedura EJ, Diener I. The efficacy of pain neuroscience education on musculoskeletal pain: a systematic review of the literature. Physiother Theor Pract 2016;32:332–55.
Hayes SC, Luoma JB, Bond FW, Masuda A, Lillis J. Acceptance and commitment therapy: model, processes and outcomes. Behav Res Ther 2006;44:1–25.
Nygaard AS, Stedenfeldt M, Øian P, Haugstad GK. Characteristics of women with chronic pelvic pain referred to physiotherapy treatment after multidisciplinary assessment: a cross-sectional study. Scand J Pain 2019;19:355–64.
Williamson A, Hoggart B. Pain: a review of three commonly used pain rating scales. J Clin Nurs 2003;14:798–804.
Ferreira-Valente MA, Pais-Ribeiro JL, Jensen MP. Validity of four pain intensity rating scales. Pain 2011;152:2399–404.
Derogatis LR, Lipman R, Rickels K, Uhlenhuth E, Covi L. The Hopkins Symptom Checklist (HSCL): a self-report symptom inventory. Behav Sci 1974;19:1–15.
Riley RD, Hayden JA, Steyerberg EW, et al. Prognosis research strategy (PROGRESS) 2: prognostic factor research. PLoS Med 2013;10:e1001380.
Fine PG. Long-term consequences of chronic pain: mounting evidence for pain as a neurological disease and parallels with other chronic disease states. Pain Med 2011;12:996–1004.
Weijenborg PTM, Ter Kuile MM, Gopie JP, Spinhoven P. Predictors of outcome in a cohort of women with chronic pelvic pain – a follow-up study. Eur J Pain 2009;13:769–75.
Rodríguez LV, Stephens AJ, Clemens JQ, et al. Symptom duration in patients with urologic chronic pelvic pain syndrome is not associated with pain severity, nonurologic syndromes and mental health symptoms: a multidisciplinary approach to the study of chronic pelvic pain network study. Urology 2019;124:14–22.
Tschudi-Madsen H, Rødevand LN, Kaarbø MB, Granan LP. Chronic widespread pain in a tertiary pain clinic: classification overlap and use of a patient generated quality of life instrument. Scand J Pain 2019;19:245–55.
Stedenfeldt M, Kvarstein G, Nilsen TIL, Schjødt B, Borchgrevink P, Halsteinli V. Pre-consultation biopsychosocial data from patients admitted for management at pain centers in Norway. Scand J Pain 2020;20:363–73.
Lai HH, Jemielita T, Sutcliffe S, Bradley CS, Naliboff B, Williams DA, Gereau RW, Kreder K, Clemens JQ, Rodriguez LV, Krieger JN, Farrar JT, Robinson N, Landis JR, MAPP Research Network. Characterization of whole body pain in urological chronic pelvic pain syndrome at baseline: a MAPP research network study. J Urol 2017;198:622–31.
IBM. IBM SPSS Statistics for Macintosh, Version 25.0. Armonk, NY: IBM Corp.; 2017.
Latthe P, Mignini L, Gray R, Hills R, Khan K. Factors predisposing women to chronic pelvic pain: systematic review. BMJ 2006;332:749–55.
Boonstra AM, Reneman MF, Waaksma BR, Schiphorst Preuper HR, Stewart RE. Predictors of multidisciplinary treatment outcome in patients with chronic musculoskeletal pain. Disabil Rehabil 2015;37:1242–50.
Gerdle B, Molander P, Stenberg G, Stålnacke B-M, Enthoven P. Weak outcome predictors of multimodal rehabilitation at one-year follow-up in patients with chronic pain – a practice based evidence study from two SQRP centres. BMC Musc Dis 2016;17:490.
Williams ACdC, Craig K. Updating the definition of pain. Pain 2016;157:2420–3.
Rooij Ad, Roorda LD, Otten RHJ, Van Der Leeden M, Dekker J, Steultjens MP. Predictors of multidisciplinary treatment outcome in fibromyalgia: a systematic review. Disabil Rehabil 2013;35:437–49.
Gerdle B, Åkerblom S, Brodda Jansen G, Enthoven P, Ernberg M, Dong HJ, Stålnacke BM, Äng BO, Boersma K. Who benefits from multimodal rehabilitation – an exploration of pain, psychological distress, and life impacts in over 35,000 chronic pain patients identified in the Swedish Quality Registry for Pain Rehabilitation. J Pain Res 2019;12:891–908.
Aguirre F, Heft J, Yunker A. Factors associated with nonadherence to pelvic floor physical therapy referral for the treatment of pelvic pain in women. Phys Ther 2019;99:946–52.

Auteurs

Ane S Nygaard (AS)

Norwegian National Advisory Unit on Incontinence and Pelvic Floor Health, University Hospital of North Norway, Tromsø, Norway.
Women's Health and Perinatology Research Group, Institute of Clinical Medicine, The Arctic University of Norway, Tromsø, Norway.

Gro K Haugstad (GK)

Institute of Physical Therapy, Oslo Met-Oslo Metropolitan University, Oslo, Norway.

Tom Wilsgaard (T)

Department of Community Medicine, UiT The Arctic University of Norway, Tromsø, Norway.

Pål Øian (P)

Department of Obstetrics and Gynecology, University Hospital of North Norway, Tromsø, Norway.

Mona Stedenfeldt (M)

Norwegian Advisory Unit on Complex Symptom Disorders, St. Olav's Hospital, Trondheim University Hospital, Trondheim, Norway.
Department of Circulation and Medical Imaging, Faculty of Medicine and Health Sciences, Norwegian University of Science and Technology (NTNU), Trondheim, Norway.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH